Close menu




November 27th, 2025 | 07:20 CET

Black Week sales, Bitcoin flop, DAX steady – another interest rate cut? Almonty, Rheinmetall, thyssenkrupp, and TKMS

  • Mining
  • Tungsten
  • Defense
  • Investments
Photo credits: pixabay.com

And up it goes again! It is the season of rising prices. After the widely expected autumn correction turned out to be very mild, many investors believe: That is it! True to the motto "Buy every dip!", they are piling back into the order books. Too few shares are available, so should investors continue buying at high prices? Caution is advised with some stocks. The euphoria surrounding the IPO of thyssenkrupp's marine subsidiary TKMS has completely evaporated, and investors in Düsseldorf-based defense group Rheinmetall are taking profits on a larger scale for the first time. After all, if the war in Ukraine ends, the rearmament cycle could slow down. We will guide you through the Advent bargain hunt!

time to read: 5 minutes | Author: André Will-Laudien
ISIN: ALMONTY INDUSTRIES INC. | CA0203987072 , RHEINMETALL AG | DE0007030009 , THYSSENKRUPP AG O.N. | DE0007500001 , TKMS AG & CO KGAA | DE000TKMS001

Table of contents:


    Almonty Industries – Hub for Western tungsten supply

    The correction appears to be over! The share price, which had dipped below EUR 5, is now back at EUR 5.40 – only quick investors can enjoy lower entry prices. Almonty Industries remains a pawn in geopolitical tensions, as the sharp swings in commodity prices in recent months have left deep scars in many investors' portfolios, but at the same time have brought the strategic importance of tungsten back into the spotlight.

    While the stock market was at times nervous about an escalation between the US administration and China and paid scarcity prices for critical metals, perceptions have now shifted: it is not short-term headlines, but reliable data on integration into Western supply chains that are becoming the real benchmark for valuation. This is precisely where Almonty comes in with its portfolio, as tungsten and molybdenum are considered rare, security-relevant raw materials that are indispensable for defense, aerospace, semiconductors, and AI infrastructure. Wherever tungsten is needed for armor, precision tools, or high-performance electronics, potential industrial customers are ready to sign long-term off-take agreements. This is driven by political pressure in the US and Europe to become less dependent on Chinese supplies.

    Almonty is underpinning this strategic status with a clear growth story: a large-scale drill program is underway at the Panasqueira mine in Portugal, preparing for expansion to the new "Level 4" production level and set to increase both annual production volume and mine life. Around 14,000 meters of drilling within twelve months and an investment volume in the low single-digit million range are intended to update the resource model, define new mineralization zones, and secure production planning for years to come. At the same time, the Company is pushing ahead with the completion of the Sangdong mine in South Korea, one of the largest and highest-grade tungsten projects in the world, which, once fully operational, could account for a large part of non-Chinese tungsten production and thus become the Group's primary source of cash flow.

    With its recent entry into the US market through the complete acquisition of the Gentung Browns Lake project in Montana, Almonty is now also establishing a presence in the most important Western defense and high-tech location. The project, located in a historic tungsten district, offers proven resources, an underground deposit in skarn rock, high metallurgical yields, and existing infrastructure, which significantly reduces development risks. Based on current planning, Almonty aims to have Gentung Browns Lake ready for production in the second half of 2026, with an expected output of around 140,000 MTU of tungsten oxide per year and exclusive rights along the entire project corridor. In combination with the ramp-up phase of Sangdong and the gradual expansion of Panasqueira, this will create a transcontinental production triangle between Europe, Asia, and North America from 2026 onwards, which will be able to serve both defense contracts and high-tech demand. On this basis, research houses see Almonty in a clear growth phase and already expect strong growth in revenue and earnings for 2026, as initial volumes from Sangdong and possible advance payments from Montana could be included in the figures, while higher tungsten prices will leverage margins. Oppenheim Research rates the stock as a "Buy" with a price target of USD 12, while Sphene Capital believes it could well reach CAD 13.50 in 36 months. So the story continues!

    Listen to charismatic CEO Lewis Black at the upcoming International Investment Forum (www.ii-forum.com) on December 3 at 4:00 p.m. CET for the latest updates.

    Rheinmetall – Peace talks please citizens, but not defense investors

    We have often discussed the temporary overvaluation of Rheinmetall. The stock market has now converted this into a 30% correction. Of course, the figures now look more relaxed again. The 2026 P/E ratio has fallen from 5.2 to 3.9, and the P/E ratio from 42 to 34. Some say it is still too high, while others say it is significantly lower and once again has potential. Since the peace talks between the US, Russia, and Ukraine still have a glimmer of hope for success, the green flag for reinvestments may not be far off. If a ceasefire is reached, Rheinmetall's share price could be expected to reach around EUR 1,200, which would then be a "conviction buy" for us, as per Goldman Sachs. So take your time and watch for a while; nothing is going to run away here. Even if Rheinmetall actually manages to meet its current revenue estimates logistically, the 2028 figures are already priced in today. However, due to the time lag in research analyses, the 12-month consensus target price reached a new all-time high of EUR 2,238 this week. Flip a coin to decide whether EUR 1,477 is attractive enough for a (re)purchase.

    thyssenkrupp and TKMS – Hand in hand downwards

    Industrial giant thyssenkrupp pulled off a real coup in October with the spin-off of its TKMS shares. This has eased the burden on the group's balance sheet, and pre-financing of revenue is no longer a drain on the weak cash reserves in Duisburg. Even though the group is coming out on top, shareholders have earned nothing. Shortly before the spin-off, the thyssenkrupp share price reached over EUR 12. However, the price fell by around EUR 4, while the new TKMS share quickly dropped back to its issue price after initial euphoria of over EUR 100. Nevertheless, three out of four experts on the LSEG platform consider the new marine stock to be worth buying. The 12-month price target is set at an average of EUR 86, which represents a 33% upside from today's price of EUR 64.


    The stock market is gearing up for the end of the year. This is leading to profit-taking in sectors that have performed well, but also to increases in sectors with good medium-term prospects. Almonty will start operations at the Sangdong mine in 2026, and thyssenkrupp can finally breathe a sigh of relief after the placement of its marine subsidiary TKMS. Rheinmetall has gained 2,000% in three years and must first grow into its current valuation. Defense investors should therefore not expect too much momentum here; rather, further consolidation is likely if the topic of "peace" comes to the fore. But Rheinmetall is clearly the new favorite stock of Germans and, after 25 years of disarmament, represents a 180-degree shift in mindset.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by André Will-Laudien on April 13th, 2026 | 09:30 CEST

    Double The Gains: 100% Rebound in Defense Stocks and Critical Metals – Rheinmetall, Antimony Resources, CSG, and Mutares in focus

    • Mining
    • antimony
    • Defense
    • CriticalMetals
    • geopolitics
    • security

    Created and published on behalf of Antimony Resources Corp.

    The stock market gives and takes. While investors were able to celebrate a massive 5% gain last week, the tide has already turned in the opposite direction this week. The reason: The hoped-for peace talks in Pakistan between the US, Israel, and Iran have failed. Since this provides no positive momentum for the economy or the already strained energy and metals markets, volatility is likely to return in some sectors. We are looking at opportunities in the critical metals sector and highlighting some stocks that are showing attractive metrics again following recent corrections.

    Read

    Commented by Mario Hose on April 13th, 2026 | 07:30 CEST

    100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec

    • Biotechnology
    • Biotech
    • Pharma
    • Investments

    Even in the spring of 2026, the stock market remains highly volatile. The upheavals caused by geopolitical crises have been and remain significant and ever-present. While heavyweights like Bayer are struggling to shake off their legal baggage and Evotec is steering into calmer waters, a stock from the back row is suddenly stepping into the spotlight. Vidac Pharma has also had a few turbulent months, and this is precisely where experienced investors now sense an opportunity. With a current share price of EUR 0.56, the company is poised for a potential recovery, an uptick, and perhaps even a complete revaluation. If the strategy pays off, the EUR 1 mark could be reached. That would be a chance to double their money for bold investors. But what is behind this optimism? In this report, we take a look at the industry giants and analyze not only them but also why, of all three, the one with the smallest market capitalization could develop the greatest momentum. It is about potential breakthroughs in cancer research and a management team that is optimizing many aspects for success.

    Read

    Commented by André Will-Laudien on April 13th, 2026 | 07:25 CEST

    Almonty Drives the Tungsten Market: Between Shortages, Price Surges, and Revaluation

    • Mining
    • Tungsten
    • Defense
    • geopolitics
    • hightech

    Major stock indices are currently experiencing heightened volatility. Following the strong rally of the past 24 months, both the S&P 500 and the DAX 40 have recently corrected by between 5% and 10%. Rising interest rates and little prospect of peace in one of the many global hotspots are weighing particularly heavily on the market. Commodities paint a different picture: industrial metals and critical materials remain in demand, led by tungsten, whose price has increased roughly tenfold over the past 24 months. Producer Almonty Industries is benefiting particularly from this; with the start of production in Sangdong, it is now entering a new operational phase and, with a market capitalization of more than EUR 4.2 billion, has made its way onto the buy lists of institutional investors. The recent consolidation appears to be over. What should investors be watching for now?

    Read